1. Home >
  2. M&A >
  3. Stake Purchase >
  4. Czech Republic >
  5. Mid Europa Partners Invests In Walmark AS

Investment Summary

Mid Europa Partners Invests In Walmark AS

On December 17, 2012, private equity firm Mid Europa Partners invested in life science company Walmark AS

Investment Highlights
  • This is Mid Europa Partners’ 1st transaction in the Life Science sector.
  • This is Mid Europa Partners’ 4th transaction in Czech Republic.
Investment Fate
  • Walmark AS was sold to a publicly-traded strategic buyer in 2019.

Investment Summary
Date 2012-12-17
Target Walmark AS
Sector Life Science
Investor(s) Mid Europa Partners
Deal Type Stake Purchase

Target

Walmark AS

Třinec, Czech Republic
Walmark is a manufacturer of consumer health products in Central Europe with a unique portfolio of well-established Consumer Health brands across multiple categories. These include vitamins and minerals, children’s health, women’s health, men’s health, joint care, digestive and intestinal, and cough and cold and are set to generate continued strong growth. The company's key brands include e.g. Biopron (gut health), Martians (children’s supplements), Urinal (urinary tract health), Proenzi (joint care), Prostenal (male health), Beliema (vaginal health) and Sinulan (respiratory health). Walmark was established in 1990 and headquartered in Třinec, Czech Republic.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Mid Europa Partners

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1999
PE ASSETS 6.2B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Mid Europa Partners is a private equity firm focused on investing in Central and Eastern Europe. Mid Europa prefers control based investments in market leading companies operating in industries with high barriers to entry. Sectors of interest include telecom, media, utilities, transportation, natural resources, industrial, healthcare, building materials, manufacturing, and agriculture. The Firm looks to commit €50 to €300 million of equity capital per transaction in businesses valued up to €500 million. Prospective transaction types include buyouts, take-privates, divestitures, turnarounds, and large scale expansions. Mid Europa Partners is the successor entity to EMP Europe Ltd, which was formed in 1999. Mid Europa has offices in Budapest, Warsaw, and London.

DEAL STATS #
Overall 24 of 44
Sector: Life Science M&A 1 of 3
Type: Stake Purchase M&A Deals 3 of 4
Country: Czech Republic M&A 4 of 4
Year: 2012 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-03 Orange Austria Telecommunication

Vienna, Austria

Orange Austria Telecommunication GmbH offers mobile telecommunications network services. Orange Austria Telecommunication GmbH was founded in 1998 and is based in Vienna, Austria.

Sell €1.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-12-21 Alpha medical a.s.

Martin, Slovakia

Alpha medical a.s. is a provider of routine and specialised tests, mainly in the areas of biochemistry, microbiology, pathology and genetics, and operates a fully integrated procurement and workflow system.

Buy -
Mergr

Solution for

Product

Company

Legal